Boston Scientific Value Stock - Dividend - Research Selection
Market price: 37,66 USD
Boston Scientific Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||1.870.000.000|
|Free cash flow||1.316.000.000|
|Liabilities & Shareholders equity||32.229.000.000|
|Diluted shares outstanding||1.416.000.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||53.326.561.280,00 USD|
|Indices||MSCI World Index,S&P 500|
|Sectors||Health Care Equipment|
|Raw Data Source||US GAAP in Millionen USD|
|Stock Split||2003-11-06,2.0000/1.0000; 1998-12-01,2.0000/1.0000|
Description of the company
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women's Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente, California and, as a result, added to its product portfolio subcutaneous implantable cardioverter defibrillator, called the S-ICD System. In November 2013, the Company announced that it has acquired Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc.